Craig Lipsay: Mr. Lipsay has an almost 30-year track record on Wall Street, including 11 years at Morgan Stanley where, as an investment banker based in Morgan Stanley’s New York City headquarters, he rose to Managing Director, Co-head of North American Structured Products and then Managing Director, Co-head of the North American Strategic Solutions Group at Merrill Lynch. He has since served as an advisor and large shareholder in several investment funds. Mr. Lipsay has an undergraduate degree from SUNY, Albany and an MBA from The Wharton School at the University of Pennsylvania. Mr. Lipsay will support the company in areas of capital markets communication and strategic planning.
Jacob Gamble: Mr. Gamble has a more than 20-year track record ranging from operations to finance. Mr. Gamble rose to the level of Vice President of Fisher Investments overseeing a significant business line during his 13-year period with that company, and worked as a Managing Director at Paulson Investments before striking out into the cannabis industry. Mr. Gamble specializes in the process of licensing, build-outs and development of vertically integrated operations. He has deep knowledge, contacts and experience within the cannabis industry. Through his finance background, Mr. Gamble also has experience in acquisitions of small private companies and operational integration of disparate businesses. Mr. Gamble has an undergraduate degree from Oregon State University and attended Stanford University for post-baccalaureate studies in economics. He has a Masters of Science degree from Florida Institute of Technology.
Chris Heath: Mr. Heath has been part of the Ventura Cannabis and Wellness family since the summer of 2015. He completed his Bachelor’s in Business Economics and received his MBA in Southern California. After becoming CEO of Ventura’s legacy business in 2017, Mr. Heath used his expertise to make fundamental changes to the company’s business model driving increased revenues and profitability. Mr. Heath has a proven track record of successfully of improving financial performance by implementing the owner-operator business model the Company plans to deploy in its newly acquired cannabis dispensaries.
Michael Hynes: Mr. Hynes has dual undergraduate degrees in Chemical Engineering and Cellular Biology from University of Michigan at Ann Arbor. Mr. Hynes has a Master of Business Administration (MBA) and a Medical Degree (MD) from University of Michigan at Ann Arbor. Mr. Hynes has a broad experience in business and medicine, working at Exis Capital, a New York-based hedge fund as well as Merck & Co., a large pharmaceutical company. Mr. Hynes has taken a keen interest in the effects of marijuana on several medical indications and the business and market opportunities opened up by these effects.
Nitin Kaushal : Mr. Kaushal has worked in senior roles with a number of Canadian investment banks focused on healthcare, including Desjardins Securities Inc, Orion Securities Inc, Vengate Capital, HSBC Securities Inc and Gordon Capital. He has held roles within the private equity/venture capital industry at MDS Capital Corp. and at PricewaterhouseCoopers in their M&A, valuation and audit groups. In addition, Mr. Kaushal has sat on a number of public and private company boards. He was awarded a Bachelor of Science (Chemistry) from the University of Toronto and is a Chartered Accountant.